Abstract:A 23-year-old woman with -14.00 diopters of myopia requested emmetropia for professional reasons. An ICM 130 V2 myopic phakic intraocular lens (IOL) (Staar Surgical AG) was implanted in the posterior chamber. Three days later, the patient developed malignant glaucoma. Pupillary block glaucoma and choroidal hemorrhage or effusion were ruled out. As maximum medical treatment failed, rapid secondary surgery was performed with sclerotomy, aspiration in the midvitreous cavity, and removal of the IOL. The follow-up … Show more
“…There have been case reports of malignant glaucoma, 11 and intractable elevation of IOP requiring filtration surgery after ICL implantation. 12 We did not report any case of cataract after implantation of either Artisan or ICL, but this may be attributed to the relatively short follow-up period.…”
Purpose To evaluate the safety and visual outcomes of two phakic intraocular lenses (IOLs) for correction of high myopia: Artisan and Visian ICL (ICL). Patients and methods In this retrospective study, a phakic IOL was implanted in 68 highly myopic eyes of 34 patients; 42 eyes received an Artisan IOL, and 26 eyes received ICL IOL.Results All patients completed a 1-year follow-up. The mean preoperative spherical equivalent (SEQ) was À12.89 ± 3.78, and À12.44±4.15 diopters (D) for Artisan and ICL (P ¼ 0.078), respectively. The mean postoperative (1-year) uncorrected distance visual acuity was 0.39±0.13 and 0.41±0.15 logMAR for Artisan and ICL, respectively (P ¼ 0.268). The mean postoperative (1-year) corrected distance visual acuity was 0.36 ± 0.12 and 0.31 ± 0.12 logMAR for Artisan and ICL, respectively (P ¼ 0.128). The mean postoperative SEQ was À0.86±0.5 and À0.63±0.38 D for Artisan and ICL, respectively (P ¼ 0.67). Intraocular pressure change at 1 year was 0.64 ± 2.7 and 1.88 ± 0.6 mm Hg for Artisan and ICL, respectively (P ¼ 0.77). Conclusion Artisan and ICL showed equal and comparable safety, predictability, and efficacy.
“…There have been case reports of malignant glaucoma, 11 and intractable elevation of IOP requiring filtration surgery after ICL implantation. 12 We did not report any case of cataract after implantation of either Artisan or ICL, but this may be attributed to the relatively short follow-up period.…”
Purpose To evaluate the safety and visual outcomes of two phakic intraocular lenses (IOLs) for correction of high myopia: Artisan and Visian ICL (ICL). Patients and methods In this retrospective study, a phakic IOL was implanted in 68 highly myopic eyes of 34 patients; 42 eyes received an Artisan IOL, and 26 eyes received ICL IOL.Results All patients completed a 1-year follow-up. The mean preoperative spherical equivalent (SEQ) was À12.89 ± 3.78, and À12.44±4.15 diopters (D) for Artisan and ICL (P ¼ 0.078), respectively. The mean postoperative (1-year) uncorrected distance visual acuity was 0.39±0.13 and 0.41±0.15 logMAR for Artisan and ICL, respectively (P ¼ 0.268). The mean postoperative (1-year) corrected distance visual acuity was 0.36 ± 0.12 and 0.31 ± 0.12 logMAR for Artisan and ICL, respectively (P ¼ 0.128). The mean postoperative SEQ was À0.86±0.5 and À0.63±0.38 D for Artisan and ICL, respectively (P ¼ 0.67). Intraocular pressure change at 1 year was 0.64 ± 2.7 and 1.88 ± 0.6 mm Hg for Artisan and ICL, respectively (P ¼ 0.77). Conclusion Artisan and ICL showed equal and comparable safety, predictability, and efficacy.
“…Improper position of the pIOL in the posterior chamber of the eye might affect neighboring anatomic structures (natural lens, iris, cornea, anterior chamber angle), raising the risk for postoperative complications. [1][2][3][4]15 Ultrasound biomicroscopy with a 50 MHz probe has a resolution (axial and lateral) of 50 mm. 6 It is the only commercially available method that allows the user to define and measure every structure of the anterior segment of the eye, including the ciliary sulcus area.…”
Section: Discussionmentioning
confidence: 99%
“…The distance between the posterior surface of the pIOL and the anterior pole of the natural lens in the center (pIOL vault) is the main criterion for correct pIOL position and is dependent on the correspondence between the PC pIOL size and the ciliary sulcus diameter. Correct sizing of pIOLs is critical to minimize the risk for some postoperative complications associated with insufficient vault (eg, subclinical or clinically significant anterior subcapsular opacities 1 ) or excessive vault (eg, pigment dispersion syndrome, secondary glaucoma [2][3][4] ).…”
“…7 In this situation, pupillary block can be relieved temporarily with cycloplegic agents, the mechanism of which is analogous to conditions in which ectopia lentis is the source of the pupillary block, as in Marfan syndrome or Weill-Marchesani syndrome. In most cases, acute pupillary block is caused by poorly functioning PIs, which are thought to be clinically patent on retroillumination but not fully perforated, in which case the block can be resolved with surgical or laser enlargement of existing iridotomies or the creation of new iridotomies.…”
We present a case of acute angle closure that occurred after insertion of an implantable contact lens (ICL). The apparent papillary-block angle closure did not resolve after 2 patent iridotomies and a surgical iridectomy, but did respond to pupil dilation (not constriction). Ultrasound biomicroscopy revealed abnormally large and irregular ciliary processes that may have contributed to the unusual behavior of the ICL-iris complex. The condition resolved after the ICL was replaced by one with a smaller haptic diameter. Routine ultrasound biomicroscopic assessment of the ciliary body anatomy preoperatively and ICL haptic positioning postoperatively may identify risk factors that could predispose ICL patients to acute angle closure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.